Ticker
FLGTCompany Name
FULGENT GENETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
---|---|---|---|
6/30/2025 | $ -32.9M | $ 479.78M | 0 |
3/31/2025 | $ -21.59M | $ 558.51M | 0 |
12/31/2024 | $ -22.33M | $ 421.58M | 0 |
9/30/2024 | $ -152.04M | $ 536.67M | 0 |
6/30/2024 | $ -124.82M | $ 694.54M | 0 |
3/31/2024 | $ -127.63M | $ 589.11M | 0 |
12/31/2023 | $ -134.12M | $ 600.82M | 0 |
9/30/2023 | $ -24.97M | $ 717.13M | 0 |
6/30/2023 | $ -26.68M | $ 1.11B | 0 |
3/31/2023 | $ 3.41M | $ 962.2M | 282.34 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for FULGENT GENETICS INC is calculated as follows: EV [ $ 702.44M ] / EBITDA [ $ 64.48M ]
(=) EV/EBITDA [ 10.89 ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 2.44K |
---|---|
min | 0.01 |
max | 40.82 |
average | 13.48 |
median | 11.75 |
std | 7.65 |